Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry.

Autor: Suwa, Michihiro1 (AUTHOR) suwa-mic@hokusetsu-hp.jp, Morii, Isao1 (AUTHOR), Kino, Masaya1 (AUTHOR), Matsui, Yumie2 (AUTHOR) yoshinaga-lasso@ezweb.ne.jp, Yoshinaga, Masahiro2 (AUTHOR), Takahashi, Hiroki3 (AUTHOR), Takagi, Masahiko3 (AUTHOR), Yoshida, Akira4 (AUTHOR) michikawa419@gmail.com, Ichikawa, Minoru4 (AUTHOR), Nakajima, Osamu5 (AUTHOR) haku-n@hera.eonet.ne.jp, Tanimura, Mitsuhiro6 (AUTHOR) mitsuhiro-tanimura@midorigaoka.or.jp, Shimoyama, Hisashi7 (AUTHOR), Saitoh, Hiroyuki8 (AUTHOR) hiro-saito@yukoukai.com, Sasaki, Isao9 (AUTHOR) yakuzaibu@ainomiyako.net, Suzuki, Takeshi10 (AUTHOR), Uemae, Satoshi10 (AUTHOR)
Zdroj: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1431. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje